Evidence map›Paper›PMID 37957566›Full record

ArticleBMC cancer2023

Construction of iron metabolism-related prognostic features of gastric cancer based on RNA sequencing and TCGA database.

Xihong Liu, Junyu Ren, Ruize Zhou, Zhengqi Wen, Zhengwei Wen, Zihao Chen, Shanshan He, Hongbin Zhang

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Iron and Cancer.Advances in experimental medicine and biology · 2025
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Xihong LiuDepartment of Oncology First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Junyu RenDepartment of Oncology First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Ruize ZhouDepartment of Oncology First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Zhengqi WenDepartment of Oncology First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Zhengwei WenDepartment of Oncology First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Zihao ChenDepartment of Oncology First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Shanshan HeDepartment of Oncology First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Hongbin ZhangDepartment of Pediatric Surgery First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650032, P. R. China. zhbwycz@163.com.
Kunming Medical University · CNFirst Affiliated Hospital of Kunming Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundResearches have manifested that the disorder of iron metabolism is participated in Gastric cancer (GC), but whether iron metabolism-relevant genes (IMRGs) is related to the survival outcome of GC remain unknown.

methodsEleven tumor as well as nine adjacent normal tissues from GC patients were underwent mRNA sequencing, and the The Cancer Genome Atlas Stomach Cancer (TCGA-STAD) datasets were acquired from the TCGA database. Cox analyses and least absolute shrinkage and selection operator (LASSO) regression were applied to build a IMRGs signature. The relationship between signature genes and the infiltration profiling of 24 immune cells were investigated using single-sample GSEA (ssGSEA). Meanwhile, the potential biological significance, genes that act synergistically with signature genes, and the upstream regulatory targets were predicted. Finally, the abundance of the signature genes were measured via the quantitative real-time PCR (qRT-PCR).

resultsA IMRGs signature was constructed according to the expression and corresponding coefficient of DOHH, P4HA3 and MMP1 (The Schoenfeld individual test showed risk score was not significant with P values = 0.83). The prognostic outcome of patients in the high-risk group was terrible (p < 0.05). Receiver operating characteristic (ROC) curves confirmed that the IMRGs signature presented good efficiency for predicting GC prognosis (AUC > 0.6). The nomogram was performed well for clinical utilize (C-index = 0.60), and the MMP1 expression significantly increased in the cohorts at age > 60 and Stage II-IV (p < 0.05). The positive correlation of P4HA3 and MMP1 expression as well as the negative correlation of DOHH expression with risk score (p < 0.0001) and worse prognosis (p < 0.05) were detected as well. Furthermore, 11 differential immune cells were associated with these signature genes (most p < 0.01). Finally, qRT-PCR revealed that the abundance of DOHH, P4HA3 and MMP1 were high in tumor cases, indicating the complex mechanism between the high expression of DOHH as a protective factor and the high expression of P4HA3 and MMP1 as the risk factors in the development of GC.

conclusionAn iron metabolism-related signature was constructed and has significant values for foretelling the OS of GC.

Indexed as

Stomach NeoplasmsHumansIronMatrix Metalloproteinase 1Procollagen-Proline DioxygenasePrognosisSequence Analysis, RNAIronMatrix Metalloproteinase 1P4HA3 protein, humanProcollagen-Proline DioxygenaseGastric cancerIron metabolism-relatedmRNA sequencingPrognostic signatureTCGA Database

Identifiers

PMID37957566
PMCPMC10644585
OpenAlexW4388651742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.